10.1016/j.cell.2019.08.003 101 RiveraD.OniskoN.CaoJ
Petersburg clinic provides medically supervised weight loss and hormone therapy, including GLP-1 medications such as semaglutide and tirzepatide, HRT, TRT, metabolic testing, advanced lab work, and structured nutrition coaching
Potential Risks: It is important to be aware of the potential long-term risks associated with both treatments
Tirzepatide targets two receptors
A certificate of analysis (COA) documents the batch identity, purity, and endotoxin results
The FDA-approved semaglutide products are Ozempic (injection for diabetes), Wegovy (injection for weight management), and Rybelsus (oral tablet for diabetes)